Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05451563 · ClinicalTrials.gov registry record · NA

Double-S: a Wearable Device for Erectile Dysfunction

A NA study of Erectile Dysfunction, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT05451563 is a NA study of Erectile Dysfunction that is actively recruiting participants, run by Stanford University. The registered enrollment target is 10 participants, below the 231-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05451563, a NA study of Erectile Dysfunction, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to use a minimally invasive erectile device for patients suffering from erectile dysfunction.

Conditions Studied

Interventions

  • DEVICE Double-S

Study Locations (1)

California

  • Stanford Healthcare, Stanford Hospital - Stanford

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2024-03-21
Est. Completion 2026-06
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT05451563

The ClinicalTrials.gov registry entry for NCT05451563 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 231-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (96% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Erectile Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which Double-S is the first listed.

NCT05451563 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05451563 about?

NCT05451563 is a clinical study titled "Double-S: a Wearable Device for Erectile Dysfunction". The purpose of this study is to use a minimally invasive erectile device for patients suffering from erectile dysfunction.

What is the current status of trial NCT05451563?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2024-03-21. Estimated completion is 2026-06.

What conditions does trial NCT05451563 study?

This clinical trial studies the following conditions: Erectile Dysfunction.

What interventions are being tested in trial NCT05451563?

The interventions under investigation include: Double-S (DEVICE).

Who is sponsoring clinical trial NCT05451563?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05451563 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Erectile Dysfunction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.